Bristol-Myers Squibb Co BMY:NYSE
RT Quote | Last NASDAQ LS, VOL From CTA | USD
After Hours: Last | 5:07 PM EDT54.77
+0.05 (+0.10%)
+0.05 (+0.10%)Volume
409,199
Close
54.72+0.26 (+0.48%)
+0.26 (+0.48%)Volume
11,075,551
52 week range
42.52 - 62.89
- Open54.56
- Day High55.09
- Day Low54.31
- Prev Close54.46
- 52 Week High62.89
- 52 Week High Date03/02/26
- 52 Week Low42.52
- 52 Week Low Date10/29/25
Latest On Bristol-Myers Squibb Co
Key Stats
- Market Cap111.742B
- Shares Out2.04B
- 10 Day Average Volume12.30M
- Dividend2.52
- Dividend Yield4.61%
- Beta0.24
Latest On Bristol-Myers Squibb Co
KEY STATS
- Open54.56
- Day High55.09
- Day Low54.31
- Prev Close54.46
- 52 Week High62.89
- 52 Week High Date03/02/26
- 52 Week Low42.52
- 52 Week Low Date10/29/25
- Market Cap111.742B
- Shares Out2.04B
- 10 Day Average Volume12.30M
- Dividend2.52
- Dividend Yield4.61%
- Beta0.24
RATIOS/PROFITABILITY
- EPS (TTM)3.56
- P/E (TTM)15.36
- Fwd P/E (NTM)8.93
- EBITDA (TTM)20.425B
- ROE (TTM)38.84%
- Revenue (TTM)48.482B
- Gross Margin (TTM)71.98%
- Net Margin (TTM)15.00%
- Debt To Equity (MRQ)221.55%
EVENTS
- Earnings Date07/30/2026(est)
- Ex Div Date04/02/2026
- Div Amount0.63
- Split Date-
- Split Factor-
Content From Our Affiliates
Related Video
watch now
Profile
MOREBristol-Myers Squibb Company is a global biopharmaceutical company. It is engaged in the discovery, development, and delivery of transformational medicines for patients facing serious diseases in areas: oncology, hematology, immunology, cardiovascular, neuroscience and other areas. Its growth portfolio includes Opdivo (nivolumab), Opdivo Qvantig (nivolumab and hyaluronidase-nvhy), Orencia (abatacept), Yervoy (ipilimumab), Reblozyl (luspatercept-aamt), Breyanzi (lisocabtagene...
Christopher Boerner Ph.D.
Chairman of the Board, Chief Executive Officer
David Elkins
Executive Vice President, Chief Financial Officer, Member of the Leadership Team
Wendy Bartie
Executive Vice President, Corporate Affairs, Member of the Leadership Team
Cari Gallman
Executive Vice President, General Counsel and Chief Policy Officer
Cristian Massacesi M.D.
Executive Vice President, Chief Medical Officer, Head of Development, Member of the Leadership Team
Address
Route 206 And Province Line Road
Princeton, NJ
08543
United States